ROBERT F APPLE

CIK 1054942 · President and CEO · last filed 2026-07-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.24M

Companies

3

Total Filings

60

Lifetime Open-Market Net

-$5.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KZIA Director $13.04 $0 1 2026-07-08
ANTARES PHARMA, INC. (ATRS) Delisted President & CEO 2,488,360 $5.59 $13.91M -$5.72M 44 2022-03-04
AIS Executive Vice President & CFO 285,231 $70.97 $20.24M $0 14 2012-05-21

Recent Filings · Page 5 of 6

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-06-05 ANTARES PHARMA, INC. (ATRS) Delisted Mixed -$407.9K EDGAR
2013-05-24 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) +67,340 $0 EDGAR
2013-05-08 ANTARES PHARMA, INC. (ATRS) Delisted Mixed -$35.5K EDGAR
2013-01-10 ANTARES PHARMA, INC. (ATRS) Delisted Mixed -$88.5K EDGAR
2012-12-06 ANTARES PHARMA, INC. (ATRS) Delisted Mixed -$88.2K EDGAR
2012-07-10 ANTARES PHARMA, INC. (ATRS) Delisted Grant (A) +25,039 $0 EDGAR
2012-05-21 AIS Grant (A) $0 EDGAR
2011-09-13 AIS Grant (A) +40,109 $0 EDGAR
2011-05-19 AIS Grant (A) +50,000 $0 EDGAR
2011-03-01 AIS Grant (A) +34,040 $0 EDGAR
Showing 4150 of 60
Page 5 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.